Acadia Healthcare Company, Inc. (ACHC)

$66.59

+1.53

(+2.35%)

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $65.48
    $67.11
    $66.59
    downward going graph

    1.67%

    Downside

    Day's Volatility :2.43%

    Upside

    0.77%

    downward going graph
  • $62.04
    $87.77
    $66.59
    downward going graph

    6.83%

    Downside

    52 Weeks Volatility :29.32%

    Upside

    24.13%

    downward going graph

Returns

PeriodAcadia Healthcare Company, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-11.59%
6.5%
0.0%
6 Months
-22.71%
7.1%
0.0%
1 Year
-11.7%
9.8%
0.0%
3 Years
5.74%
14.2%
-20.2%

Highlights

Market Capitalization
6.0B
Book Value
$31.3
Earnings Per Share (EPS)
-0.13
PEG Ratio
1.32
Wall Street Target Price
88.67
Profit Margin
-0.38%
Operating Margin TTM
16.78%
Return On Assets TTM
6.2%
Return On Equity TTM
-0.12%
Revenue TTM
3.0B
Revenue Per Share TTM
32.79
Quarterly Revenue Growth YOY
9.1%
Gross Profit TTM
1.1B
EBITDA
660.5M
Diluted Eps TTM
-0.13
Quarterly Earnings Growth YOY
0.15
EPS Estimate Current Year
3.49
EPS Estimate Next Year
3.92
EPS Estimate Current Quarter
0.81
EPS Estimate Next Quarter
0.95

Analyst Recommendation

Buy
    77%Buy
    22%Hold
    0
    0%Sell
Based on 18 Wall street analysts offering stock ratings for Acadia Healthcare Company, Inc.(by analysts ranked 0 to 5 stars)
Based on 18 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
14
13
Hold
4
3
3
Sell
00
1
1

Analyst Forecast

What analysts predicted

Upside of 33.16%

Current $66.59
Target $88.67

Company Financials

FY18Y/Y Change
Revenue
3.0B
↑ 6.21%
Net Income
-175.8M
↓ 187.95%
Net Profit Margin
-5.83%
↓ 12.88%
FY19Y/Y Change
Revenue
3.1B
↑ 3.15%
Net Income
108.9M
↓ 161.98%
Net Profit Margin
3.51%
↑ 9.34%
FY20Y/Y Change
Revenue
2.1B
↓ 32.74%
Net Income
143.2M
↑ 31.46%
Net Profit Margin
6.85%
↑ 3.34%
FY21Y/Y Change
Revenue
2.3B
↑ 10.74%
Net Income
190.6M
↑ 33.13%
Net Profit Margin
8.24%
↑ 1.39%
FY22Y/Y Change
Revenue
2.6B
↑ 12.79%
Net Income
273.1M
↑ 43.28%
Net Profit Margin
10.46%
↑ 2.22%
FY23Y/Y Change
Revenue
2.9B
↑ 12.2%
Net Income
-21.7M
↓ 107.93%
Net Profit Margin
-0.74%
↓ 11.2%
Q4 FY22Q/Q Change
Revenue
675.3M
↑ 1.28%
Net Income
61.1M
↓ 14.03%
Net Profit Margin
9.05%
↓ 1.61%
Q1 FY23Q/Q Change
Revenue
704.3M
↑ 4.29%
Net Income
66.0M
↑ 8.0%
Net Profit Margin
9.37%
↑ 0.32%
Q2 FY23Q/Q Change
Revenue
731.3M
↑ 3.84%
Net Income
72.3M
↑ 9.52%
Net Profit Margin
9.89%
↑ 0.52%
Q3 FY23Q/Q Change
Revenue
750.3M
↑ 2.6%
Net Income
-217.7M
↓ 401.12%
Net Profit Margin
-29.02%
↓ 38.91%
Q4 FY23Q/Q Change
Revenue
742.8M
↓ 1.0%
Net Income
57.7M
↓ 126.52%
Net Profit Margin
7.77%
↑ 36.79%
Q1 FY24Q/Q Change
Revenue
768.1M
↑ 3.4%
Net Income
76.4M
↑ 32.31%
Net Profit Margin
9.95%
↑ 2.18%
FY18Y/Y Change
Total Assets
6.2B
↓ 3.92%
Total Liabilities
3.8B
↓ 0.32%
FY19Y/Y Change
Total Assets
6.9B
↑ 11.45%
Total Liabilities
4.4B
↑ 13.92%
FY20Y/Y Change
Total Assets
6.5B
↓ 5.52%
Total Liabilities
4.6B
↑ 5.17%
FY21Y/Y Change
Total Assets
4.8B
↓ 26.64%
Total Liabilities
2.2B
↓ 52.49%
FY22Y/Y Change
Total Assets
5.0B
↑ 4.61%
Total Liabilities
2.1B
↓ 4.5%
FY23Y/Y Change
Total Assets
5.4B
↑ 7.44%
Total Liabilities
2.5B
↑ 18.41%
Q4 FY22Q/Q Change
Total Assets
5.0B
↑ 0.91%
Total Liabilities
2.1B
↓ 1.15%
Q1 FY23Q/Q Change
Total Assets
5.0B
↑ 1.13%
Total Liabilities
2.1B
↑ 1.31%
Q2 FY23Q/Q Change
Total Assets
5.2B
↑ 2.1%
Total Liabilities
2.1B
↑ 1.15%
Q3 FY23Q/Q Change
Total Assets
5.3B
↑ 3.81%
Total Liabilities
2.5B
↑ 18.59%
Q4 FY23Q/Q Change
Total Assets
5.4B
↑ 0.24%
Total Liabilities
2.5B
↓ 2.56%
Q1 FY24Q/Q Change
Total Assets
5.5B
↑ 2.96%
Total Liabilities
2.5B
↑ 2.86%
FY18Y/Y Change
Operating Cash Flow
414.1M
↑ 3.63%
Investing Cash Flow
-361.0M
↑ 7.26%
Financing Cash Flow
-67.3M
↑ 12.08%
FY19Y/Y Change
Operating Cash Flow
332.9M
↓ 19.6%
Investing Cash Flow
-201.1M
↓ 44.28%
Financing Cash Flow
-61.6M
↓ 8.47%
FY20Y/Y Change
Operating Cash Flow
658.8M
↑ 97.9%
Investing Cash Flow
-281.8M
↑ 40.12%
Financing Cash Flow
-51.5M
↓ 16.43%
FY21Y/Y Change
Operating Cash Flow
374.5M
↓ 43.16%
Investing Cash Flow
1.0B
↓ 461.07%
Financing Cash Flow
-1.6B
↑ 3086.59%
FY22Y/Y Change
Operating Cash Flow
380.6M
↑ 1.63%
Investing Cash Flow
-305.8M
↓ 130.05%
Financing Cash Flow
-110.9M
↓ 93.24%
Q4 FY22Q/Q Change
Operating Cash Flow
113.5M
↑ 176.69%
Investing Cash Flow
-92.0M
↑ 17.94%
Financing Cash Flow
-17.3M
↓ 948.16%
Q1 FY23Q/Q Change
Operating Cash Flow
44.4M
↓ 60.89%
Investing Cash Flow
-66.9M
↓ 27.29%
Financing Cash Flow
-11.3M
↓ 34.56%

Technicals Summary

Sell

Neutral

Buy

Acadia Healthcare Company, Inc. is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc.
-3.01%
-22.71%
-11.7%
5.74%
95.96%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
6.75%
1.59%
-22.77%
-49.63%
-45.76%
Hca Holdings, Inc.
Hca Holdings, Inc.
3.62%
24.47%
25.02%
43.55%
143.2%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
10.35%
80.65%
95.1%
108.93%
580.33%
Universal Health Services Inc.
Universal Health Services Inc.
8.08%
30.09%
44.94%
32.59%
34.96%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
0.24%
32.97%
40.81%
19.01%
139.9%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc.
24.83
NA
1.32
3.49
0.0
0.06
NA
31.3
Fresenius Medical Care Ag
Fresenius Medical Care Ag
22.58
22.58
0.39
1.5
0.05
0.03
0.03
47.4
Hca Holdings, Inc.
Hca Holdings, Inc.
16.16
16.16
1.44
21.86
0.74
0.11
0.01
-6.06
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
5.46
5.46
1.74
8.98
0.54
0.07
NA
16.09
Universal Health Services Inc.
Universal Health Services Inc.
15.8
15.8
1.87
13.79
0.13
0.06
0.0
93.48
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
16.31
16.31
1.16
9.32
0.43
0.06
NA
10.56
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc.
Buy
$6.0B
95.96%
24.83
-0.38%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$11.9B
-45.76%
22.58
2.48%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$90.1B
143.2%
16.16
8.4%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$14.6B
580.33%
5.46
12.54%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$12.4B
34.96%
15.8
5.57%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$12.6B
139.9%
16.31
6.61%

Insights on Acadia Healthcare Company, Inc.

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 742.8M → 768.05M (in $), with an average increase of 3.3% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -217.71M → 76.38M (in $), with an average increase of 250.8% per quarter

  • Vs THC

    In the last 1 year, Tenet Healthcare Corp.  has given 95.1% return, outperforming this stock by 106.8%

  • Vs THC

    In the last 3 years, Tenet Healthcare Corp.  has given 108.9% return, outperforming this stock by 103.2%

Institutional Holdings

  • Vanguard Group Inc

    9.55%
  • T. Rowe Price Investment Management,Inc.

    9.19%
  • BlackRock Inc

    8.87%
  • Wellington Management Company LLP

    8.53%
  • FMR Inc

    5.81%
  • Amvescap Plc.

    3.54%

Company Information

acadia is a provider of inpatient and outpatient behavioral health and addiction treatment services. acadia operates a network of 225 behavioral healthcare facilities with approximately 9,190 beds in 37 states, the united kingdom and puerto rico. acadia provides psychiatric and chemical dependency services to its patients in a variety of settings, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs. acadia healthcare’s behavioral health treatment facilities are specialized solely in helping children, teenagers and adults suffering from mental health disorders and/or alcohol and drug addiction.

Organization
Acadia Healthcare Company, Inc.
Employees
23500
CEO
Mr. Christopher Howal Hunter
Industry
Health Services

FAQs